Literature DB >> 19327119

HCV genetic variability: from quasispecies evolution to genotype classification.

Claudio Argentini1, Domenico Genovese, Stefano Dettori, Maria Rapicetta.   

Abstract

HCV is a ssRNA virus belonging to the Flaviviruses and is found worldwide worldwide in humans. Following primary infection, persistent infection develops in more than 85% of cases, which in up to 30% of cases, may progress to liver disease, cirrhosis and hepatocellular carcinoma. The virus presents a high degree of genetic variability owing to the combination of a lack of proofreading by the RNA-dependent RNA polymerase and a high level of viral replication. This genetic variability allows the classification of genotypes, subtypes, isolates and quasispecies to which epidemiological and pathogenetic significance may be associated. The features and biological implications of HCV variability and of quasispecies dynamics in infection transmission, mechanisms of chronicity and resistance to antiviral therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19327119     DOI: 10.2217/fmb.09.8

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  16 in total

Review 1.  Hepatitis C virus genetic variability and evolution.

Authors:  Natalia Echeverría; Gonzalo Moratorio; Juan Cristina; Pilar Moreno
Journal:  World J Hepatol       Date:  2015-04-28

2.  Both innate and adaptive immunity mediate protective immunity against hepatitis C virus infection in chimpanzees.

Authors:  Heidi Barth; Jolanta Rybczynska; Romuald Patient; Youkyung Choi; Ronda K Sapp; Thomas F Baumert; Kris Krawczynski; T Jake Liang
Journal:  Hepatology       Date:  2011-08-11       Impact factor: 17.425

Review 3.  Hepatitis C virus: Promising discoveries and new treatments.

Authors:  Juliana Cristina Santiago Bastos; Marina Aiello Padilla; Leonardo Cardia Caserta; Noelle Miotto; Aline Gonzalez Vigani; Clarice Weis Arns
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

4.  Resistance analysis of the hepatitis C virus NS3 protease inhibitor asunaprevir.

Authors:  Fiona McPhee; Jacques Friborg; Steven Levine; Chaoqun Chen; Paul Falk; Fei Yu; Dennis Hernandez; Min S Lee; Susan Chaniewski; Amy K Sheaffer; Claudio Pasquinelli
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

5.  Early viral kinetics during hepatitis C virus genotype 6 treatment according to IL28B polymorphisms.

Authors:  Srunthron Akkarathamrongsin; Sunchai Payungporn; Vo Duy Thong; Kittiyod Poovorawan; Phisit Prapunwattana; Yong Poovorawan; Pisit Tangkijvanich
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 6.  HCV E2 core structures and mAbs: something is still missing.

Authors:  Matteo Castelli; Nicola Clementi; Giuseppe A Sautto; Jennifer Pfaff; Kristen M Kahle; Trevor Barnes; Benjamin J Doranz; Matteo Dal Peraro; Massimo Clementi; Roberto Burioni; Nicasio Mancini
Journal:  Drug Discov Today       Date:  2014-08-27       Impact factor: 7.851

7.  Molecular study of HCV detection, genotypes and their routes of transmission in North West Frontier Province, Pakistan.

Authors:  Sher Zaman Safi; Yasir Waheed; Joharia Sadat; Sadia Salahuddin; Umar Saeed; Muhammad Ashraf
Journal:  Asian Pac J Trop Biomed       Date:  2012-07

8.  Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing.

Authors:  Akihiro Nasu; Hiroyuki Marusawa; Yoshihide Ueda; Norihiro Nishijima; Ken Takahashi; Yukio Osaki; Yukitaka Yamashita; Tetsuro Inokuma; Takashi Tamada; Takeshi Fujiwara; Fumiaki Sato; Kazuharu Shimizu; Tsutomu Chiba
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

9.  The inhibitory effects of anacardic acid on hepatitis C virus life cycle.

Authors:  Jana Hundt; Zhubing Li; Qiang Liu
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

Review 10.  MicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapy.

Authors:  Archana Gupta; Gokul Swaminathan; Julio Martin-Garcia; Sonia Navas-Martin
Journal:  Viruses       Date:  2012-10-26       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.